chevron_leftBack
As of 23 June 2026, BioGend Therapeutics Co., Ltd. has a market cap of $113.34M USD, ranking #24662 globally and #1299 in Taiwan.
It ranks #5692 in the Industrials sector, and #634 in the Specialty Business Services industry.
Key Stats
Market Cap
$113.34MUSD
3.59B TWD
Enterprise Value
$97.92MUSD
3.1B TWD
Revenue (TTM)
$7.01MUSD
222.34M TWD
EBITDA (TTM)
-$2.04MUSD
-64.41M TWD
Net Income (TTM)
-$2.67MUSD
-84.61M TWD
EBITDA Margin
-29%
Profit Margin
-38%
PS Ratio
16.2
PB Ratio
4.7
Company Profile
Country (HQ)
Sector
Industrials
Industry
Specialty Business Services
CEO
Te-Li Chen
open_in_new
Employees
27
Founded
2016
Website
biogend.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.9% | -4.8% | -15% | -23% | -33% | 3.4% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
6733
博晟生醫股份有限公司 Ordinary Shares
ISIN: TW0006733009
Shares Out.:
Shares Outstanding:
132.936M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
29.15 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About BioGend Therapeutics Co., Ltd.
BioGend Therapeutics Co., Ltd. engages in the research and development, and sale of orthopedic medical devices and related products. The company offers RevoCart, an autologous cartilage repair system; and SoufCut, an autologous adipose tissue collection system. It develops BiG-001, an osteoinductive bone graft substitute; BiG-006 for lumbar interbody fusion; and BiG-009, an autologous cartilage repair system for articaular cartilage. The company operates in Taiwan, Hongkong, Chinese Mainland, and Malaysia. BioGend Therapeutics Co., Ltd. was founded in 2016 and is based in Taipei, Taiwan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 2449
|
$10.93B
10K%
346.65B TWD
|
43.7
|
|
TPEX: 3264
|
$2.98B
3K%
94.55B TWD
|
33.6
|
|
TWSE: 6257
|
$2.68B
2K%
84.98B TWD
|
31.1
|
|
TWSE: 7799
|
$1.9B
2K%
60.17B TWD
|
-
|
|
TWSE: 9917
|
$1.6B
1K%
50.84B TWD
|
16.9
|
|
TWSE: 2258
|
$1.57B
1K%
49.77B TWD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: SHOP
|
$158.14B
139K%
|
129.8
|
|
STO: VSURE
|
$131.7B
116K%
114.8B EUR
|
-
|
|
NASDAQ: CTAS
|
$69.6B
61K%
|
36.8
|
|
LSE: REL
|
$63.18B
56K%
47.6B GBP
|
23.9
|
|
NASDAQ: PYPL
|
$45.83B
40K%
|
9.4
|
|
|
T
NEO: TRI
|
$41.8B
37K%
56.91B CAD
|
-
|
chevron_leftBack